Catalyst Wire Dossier Catalyst Wire Dossier

Egaten

triclabendazole · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Egaten, covering 2019-02-13 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). [Phase 4]

See pricing